PharmAbcine Inc - Product Pipeline Review - 2016

  • ID: 4043286
  • Company Profile
  • 38 pages
  • Global Markets Direct
  • Pharmabcine
1 of 4
PharmAbcine Inc - Product Pipeline Review - 2016

Summary:

‘PharmAbcine Inc - Product Pipeline Review - 2016’, provides an overview of the PharmAbcine Inc’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by PharmAbcine Inc, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from our proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information.

Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope:

- The report provides a snapshot of the pipeline therapeutic landscape of PharmAbcine Inc
- The report provides overview of PharmAbcine Inc including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses PharmAbcine Inc’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features PharmAbcine Inc’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to Buy:

- Evaluate PharmAbcine Inc’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for PharmAbcine Inc
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding PharmAbcine Inc’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
Introduction

PharmAbcine Inc Snapshot

PharmAbcine Inc Overview

Key Facts

PharmAbcine Inc - Research and Development Overview

Key Therapeutic Areas

PharmAbcine Inc - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

PharmAbcine Inc - Pipeline Products Glance

PharmAbcine Inc - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Discovery Products/Combination Treatment Modalities

PharmAbcine Inc - Drug Profiles

Monoclonal Antibody to Antagonize c-Met for Oncology and Inflammatory Disorders - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Monoclonal Antibody to Antagonize EGFR for Oncology and Inflammatory Disorders - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Monoclonal Antibody to Antagonize HER2 for Oncology and Inflammatory Disorders - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Monoclonal Antibody to Antagonize IGFR-1 for Oncology and Inflammatory Disorders - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Monoclonal Antibody to Antagonize VEGFR-1 for Oncology and Inflammatory Disorders - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Monoclonal Antibody to Antagonize VEGFR-3 for Oncology and Inflammatory Disorders - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Monoclonal Antibody to Inhibit DLL4 for Oncology and Inflammatory Disorders - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Monoclonal Antibody to Inhibit EPCAM for Oncology and Inflammatory Disorders - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Monoclonal Antibody to Target CD-20 for Oncology and Inflammatory Disorders - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

PMC-001 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

PMC-002 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

PMC-201 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

TTAC-0001 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

PharmAbcine Inc - Pipeline Analysis

PharmAbcine Inc - Pipeline Products by Target

PharmAbcine Inc - Pipeline Products by Route of Administration

PharmAbcine Inc - Pipeline Products by Molecule Type

PharmAbcine Inc - Pipeline Products by Mechanism of Action

PharmAbcine Inc - Dormant Projects

PharmAbcine Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables:

PharmAbcine Inc, Key Facts

PharmAbcine Inc - Pipeline by Indication, 2016

PharmAbcine Inc - Pipeline by Stage of Development, 2016

PharmAbcine Inc - Monotherapy Products in Pipeline, 2016

PharmAbcine Inc - Preclinical, 2016

PharmAbcine Inc - Discovery, 2016

PharmAbcine Inc - Pipeline by Target, 2016

PharmAbcine Inc - Pipeline by Route of Administration, 2016

PharmAbcine Inc - Pipeline by Molecule Type, 2016

PharmAbcine Inc - Pipeline Products by Mechanism of Action, 2016

PharmAbcine Inc - Dormant Developmental Projects,2016

PharmAbcine Inc, Other Locations

List of Figures:

PharmAbcine Inc - Pipeline by Top 10 Indication, 2016

PharmAbcine Inc - Pipeline by Stage of Development, 2016

PharmAbcine Inc - Monotherapy Products in Pipeline, 2016

PharmAbcine Inc - Pipeline by Top 10 Target, 2016

PharmAbcine Inc - Pipeline by Molecule Type, 2016

PharmAbcine Inc - Pipeline Products by Top 10 Mechanism of Action,
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll